tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
tabrecta 150 mg
novartis pharma gmbh - germania - capmatinibum - compr. film. - 150mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
tabrecta 200 mg
novartis pharma gmbh - germania - capmatinibum - compr. film. - 200mg - inhibitori de protein-kinaza alti inhibitori de protein kinaza
rosucard 10 mg
zentiva, k.s. - republica ceha - rosuvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
rosucard 20 mg
zentiva, k.s. - republica ceha - rosuvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
rosucard 40 mg
zentiva, k.s. - republica ceha - rosuvastatinum - compr. film. - 40mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
rosuvastatina teva 10 mg
merckle gmbh - germania - rosuvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
rosuvastatina teva 20 mg
merckle gmbh - germania - rosuvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
rosuvastatina msn laboratories 10 mg
pharmadox healthcare limited - malta - rosuvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa
rosuvastatina msn laboratories 20 mg
pharmadox healthcare limited - malta - rosuvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa